Cerity Partners
BLFS icon

Cerity Partners’s BioLife Solutions BLFS Stock Holding History

Cerity Partners’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
57,506
+23
+0% +$538 ﹤0.01% 1705
2026
Q1 		$1.1M Buy
57,483
+13,037
+29% +$288K ﹤0.01% 1807
2025
Q4 		$1.07M Sell
44,446
-3,181
-7% -$83.2K ﹤0.01% 1685
2025
Q3 		$1.21M Buy
47,627
+6
+0% +$142 ﹤0.01% 1510
2025
Q2 		$1.03M Sell
47,621
-982
-2% -$22.1K ﹤0.01% 1514
2025
Q1 		$1.11M Buy
48,603
+9,015
+23% +$237K ﹤0.01% 1385
2024
Q4 		$1.02M Sell
39,588
-5,326
-12% -$133K ﹤0.01% 1399
2024
Q3 		$1.12M Buy
44,914
+2,776
+7% +$65.6K ﹤0.01% 1344
2024
Q2 		$903K Sell
42,138
-6,576
-13% -$128K ﹤0.01% 1270
2024
Q1 		$904K Buy
48,714
+21,773
+81% +$381K ﹤0.01% 1326
2023
Q4 		$438K Buy
+26,941
New +$344K ﹤0.01% 1331
2023
Q3 		– Sell
-24,437
Closed -$540K – 1422
2023
Q2 		$540K Buy
24,437
+14,700
+151% +$310K ﹤0.01% 1145
2023
Q1 		$212K Buy
+9,737
New +$219K ﹤0.01% 1688
2022
Q1 		– Sell
-5,671
Closed -$212K – 952
2021
Q4 		$212K Buy
+5,671
New +$243K ﹤0.01% 912

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cerity Partners's BLFS Position: Q2 2026 in Review

Cerity Partners increased its BioLife Solutions (BLFS) stake by 0.04% in Q2 2026, buying an estimated $538 and bringing the position to 57,506 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

Cerity Partners first reported a position in BLFS in Q4 2021 and has held it in 14 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Cerity Partners held 57,506 shares of BioLife Solutions worth $1.62M as of Q2 2026.
  • Cerity Partners bought 23 BioLife Solutions shares in Q2 2026, an estimated $538.
  • BioLife Solutions made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1705 holding.
  • Cerity Partners first reported a position in BioLife Solutions in Q4 2021 and has held it in 14 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.